Slate Run Pharmaceuticals recalls
1 recall filed under Slate Run Pharmaceuticals. The most recent was published March 4, 2026.
-
Class III · 8 months ago
Slate Run Pharmaceuticals Eptifibatide Injection recall: Labeling: Not Elsewhere Classified. The carton for Eptifibatide Injection 75
Labeling: Not Elsewhere Classified. The carton for Eptifibatide Injection 75 mg/100 mL states 75 mg/100 mL vial for weight-adjusted bolus dosing. The…
About this page
Slate Run Pharmaceuticals appears here because a federal agency named it as the recalling firm or the brand on the label. A recall is not a judgement about everything the company sells — it covers only the lot codes and models listed in each notice.